Order Article Reprints

Zinevich TV, Maslov IO, Kirichenko OG, Shorshnev SV, Gureev MA, Dolgushin FM, Porozov YB, Trukhan VM. 3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM. Pharmaceuticals. 2025; 18(5):642. https://doi.org/10.3390/ph18050642

Zinevich, Tatiana V., Ivan O. Maslov, Olga G. Kirichenko, Sergey V. Shorshnev, Maxim A. Gureev, Fedor M. Dolgushin, Yuri B. Porozov, and Vladimir M. Trukhan. 2025. "3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM" Pharmaceuticals 18, no. 5: 642. https://doi.org/10.3390/ph18050642

Zinevich, T. V., Maslov, I. O., Kirichenko, O. G., Shorshnev, S. V., Gureev, M. A., Dolgushin, F. M., Porozov, Y. B., & Trukhan, V. M. (2025). 3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM. Pharmaceuticals, 18(5), 642. https://doi.org/10.3390/ph18050642